Biocon QIP closes at Rs 368.35, 5% below floor price

Qip At DiscountFund Raising View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹378.90

prior close

₹380.20

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.0%-0.7% vs market

Pharmaceuticals peers, median of 156sector-0.8%+0.2% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.1

15m

+0.4

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.0-0.7-0.8+0.2

Next day

-1.0-0.4-0.6-1.8+0.8

-3.7-2.9-0.8-3.9+0.3

-3.7-3.9+0.2-4.7+1.0

-1.7-2.7+1.0-3.8+2.1

-3.1-4.4+1.3-5.1+2.0

-2.3-2.3-0.1-4.4+2.1

15d

-1.6+1.4-3.0-1.5-0.1

+0.4+0.1+0.3-4.0+4.3

-0.6-8.2+7.7-10.0+9.4

-7.6-0.8-6.7-1.9-5.7

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon closed its QIP issue on Jan 14, 2026, allotting about 11.27 crore equity shares at Rs 368.35 per share. This is a 5% discount of Rs 19.39 to the floor price of Rs 387.74, raising approximately Rs 4,149 crore. The issue was opened on Jan 12, 2026 under SEBI ICDR rules. Each share carries a premium of Rs 363.35 over its face value of Rs 5.

Likely market impact

Dilution for existing shareholders; pricing below floor suggests softer demand and may pressure the stock in the near term.